CKS2 and lung colloid adenocarcinoma: Moreover, CKS2 has a good ability in distinguish stages I–III invasive non-mucinous lung adenocarcinoma patients from healthy samples, indicating that CKS2 has the potential to be used as a diagnostic biomarker for stages I–III invasive non-mucinous lung adenocarcinoma.